Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Teva Rises to Five-Month High on U.S.-Traded Shares Advance

Dec. 18 (Bloomberg) -- Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, climbed to the highest level in almost five months following an increase in its U.S.-traded stock.

The shares in the Petach-Tikva, Israel-based company rose to the highest level since July 20, gaining 2.8 percent to 162.90 shekels, or the equivalent of $42.89, at the 4:30 p.m. close in Tel Aviv. Teva’s U.S.-traded shares closed at $42.72 on Dec. 16.

Teva has declined 12 percent in Tel Aviv this year.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at

To contact the editor responsible for this story: Claudia Maedler at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.